Literature DB >> 31761413

PI-RADS 3 Lesions: Role of Prostate MRI Texture Analysis in the Identification of Prostate Cancer.

Dario Giambelluca1, Roberto Cannella1, Federica Vernuccio2, Albert Comelli3, Alice Pavone1, Leonardo Salvaggio1, Massimo Galia1, Massimo Midiri1, Roberto Lagalla1, Giuseppe Salvaggio1.   

Abstract

PURPOSE: To determine the diagnostic performance of texture analysis of prostate MRI for the diagnosis of prostate cancer among Prostate Imaging Reporting and Data System (PI-RADS) 3 lesions.
MATERIALS AND METHODS: Forty-three patients with at least 1 PI-RADS 3 lesion on prostate MRI performed between June 2016 and January 2019 were retrospectively included. Reference standard was pathological analysis of radical prostatectomy specimens or MRI-targeted biopsies. Texture analysis extraction of target lesions was performed on axial T2-weighted images and apparent diffusion coefficient (ADC) maps using a radiomic software. Lesions were categorized as prostate cancer (Gleason score [GS] ≥ 6), and no prostate cancer. Statistical analysis was performed using the generalized linear model (GLM) regression and the discriminant analysis (DA). AUROC with 95% confidence intervals were calculated to assess the diagnostic performance of standalone features and predictive models for the diagnosis of prostate cancer (GS ≥ 6) and clinically-significant prostate cancer (GS ≥ 7).
RESULTS: The analysis of 46 PI-RADS 3 lesions (ie, 27 [58.7%] no prostate cancers; 19 [41.3%] prostate cancers) revealed 9 and 6 independent texture parameters significantly correlated with the final histopathological results on T2-weighted and ADC maps images, respectively. The resulting GLM and DA predictive models for the diagnosis of prostate cancer yielded an AUROC of 0.775 and 0.779 on T2-weighted images or 0.815 and 0.821 on ADC maps images. For the diagnosis of clinically-significant prostate cancer, the resulting GLM and DA predictive models for the diagnosis of prostate cancer yielded an AUROC of 0.769 and 0.817 on T2-weighted images or 0.749 and 0.744 on ADC maps images.
CONCLUSION: Texture analysis of PI-RADS 3 lesions on T2-weighted and ADC maps images helps identifying prostate cancer. The good diagnostic performance of the combination of multiple radiomic features for the diagnosis of prostate cancer may help predicting lesions where aggressive management may be warranted.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31761413     DOI: 10.1067/j.cpradiol.2019.10.009

Source DB:  PubMed          Journal:  Curr Probl Diagn Radiol        ISSN: 0363-0188


  12 in total

1.  Texture analysis on bi-parametric MRI for evaluation of aggressiveness in patients with prostate cancer.

Authors:  Tae Wook Baek; Seung Ho Kim; Sang Joon Park; Eun Joo Park
Journal:  Abdom Radiol (NY)       Date:  2020-08-01

2.  Development of a new fully three-dimensional methodology for tumours delineation in functional images.

Authors:  Albert Comelli; Samuel Bignardi; Alessandro Stefano; Giorgio Russo; Maria Gabriella Sabini; Massimo Ippolito; Anthony Yezzi
Journal:  Comput Biol Med       Date:  2020-03-16       Impact factor: 4.589

3.  Performance of Radiomics Features in the Quantification of Idiopathic Pulmonary Fibrosis from HRCT.

Authors:  Alessandro Stefano; Mauro Gioè; Giorgio Russo; Stefano Palmucci; Sebastiano Emanuele Torrisi; Samuel Bignardi; Antonio Basile; Albert Comelli; Viviana Benfante; Gianluca Sambataro; Daniele Falsaperla; Alfredo Gaetano Torcitto; Massimo Attanasio; Anthony Yezzi; Carlo Vancheri
Journal:  Diagnostics (Basel)       Date:  2020-05-15

4.  Evaluation of a multiparametric MRI radiomic-based approach for stratification of equivocal PI-RADS 3 and upgraded PI-RADS 4 prostatic lesions.

Authors:  Valentina Brancato; Marco Aiello; Luca Basso; Serena Monti; Luigi Palumbo; Giuseppe Di Costanzo; Marco Salvatore; Alfonso Ragozzino; Carlo Cavaliere
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

5.  Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer.

Authors:  Mou Li; Ling Yang; Yufeng Yue; Jingxu Xu; Chencui Huang; Bin Song
Journal:  Front Oncol       Date:  2021-02-17       Impact factor: 6.244

6.  Advanced Imaging Analysis in Prostate MRI: Building a Radiomic Signature to Predict Tumor Aggressiveness.

Authors:  Anna Damascelli; Francesca Gallivanone; Giulia Cristel; Claudia Cava; Matteo Interlenghi; Antonio Esposito; Giorgio Brembilla; Alberto Briganti; Francesco Montorsi; Isabella Castiglioni; Francesco De Cobelli
Journal:  Diagnostics (Basel)       Date:  2021-03-26

7.  Can machine learning-based analysis of multiparameter MRI and clinical parameters improve the performance of clinically significant prostate cancer diagnosis?

Authors:  Tao Peng; JianMing Xiao; Lin Li; BingJie Pu; XiangKe Niu; XiaoHui Zeng; ZongYong Wang; ChaoBang Gao; Ci Li; Lin Chen; Jin Yang
Journal:  Int J Comput Assist Radiol Surg       Date:  2021-10-22       Impact factor: 2.924

8.  Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions.

Authors:  Tianping Li; Linna Sun; Qinghe Li; Xunrong Luo; Mingfang Luo; Haizhu Xie; Peiyuan Wang
Journal:  Front Oncol       Date:  2022-01-26       Impact factor: 6.244

9.  Utility of Clinical-Radiomic Model to Identify Clinically Significant Prostate Cancer in Biparametric MRI PI-RADS V2.1 Category 3 Lesions.

Authors:  Pengfei Jin; Liqin Yang; Xiaomeng Qiao; Chunhong Hu; Chenhan Hu; Ximing Wang; Jie Bao
Journal:  Front Oncol       Date:  2022-02-24       Impact factor: 6.244

10.  A New Framework for Precise Identification of Prostatic Adenocarcinoma.

Authors:  Sarah M Ayyad; Mohamed A Badawy; Mohamed Shehata; Ahmed Alksas; Ali Mahmoud; Mohamed Abou El-Ghar; Mohammed Ghazal; Moumen El-Melegy; Nahla B Abdel-Hamid; Labib M Labib; H Arafat Ali; Ayman El-Baz
Journal:  Sensors (Basel)       Date:  2022-02-26       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.